-
-
-
-
-
-
-
William Blair Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "entering 2026 with increasing momentum"
-
-
-
-
-
-
-
Tenaya Therapeutics, Inc. (TNYA) Tops Q3 EPS by 3c
-
-
-
-
-
-
-
Tenaya Therapeutics (TNYA) Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
-
-
-
-
-
-
-
Tenaya Therapeutics (TNYA) Receives $8M Clinical Grant from California Institute for Regenerative Medicine
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Tenaya Therapeutics Inc (TNYA)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)
-
-
483,150 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


